Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Enhancing resistance to blast disease through CRISPR/Cas9 gene editing technology in OsHDT701 gene in RPBio-226 rice cv. (Oryza sativa L.)

Shravya Mathsyaraja, Saida Lavudi, Prathap Reddy Vutukuri.




Abstract

Blast is the most common destructive disease affecting rice production globally. Resistance by the host organism has emerged to be the most practical and cost-efficient method for controlling rice blasts. Recent research has demonstrated that sequence-specific nucleases, which clustered regularly, interspaced short palindrome repeats (CRISPR)/Cas9 technology is thought to be the most successful and potent tool for enhancing crops through gene-specific genome editing. However, there have not been many reports of their use in improving superior rice varieties. In this research study, we describe the Cas9-OsHDT-sgRNA-expressing gene cassette development that targets the OsHDT701 gene in rice and increases rice’s blast resistance. The target location of these plants had a deletion (Del) alteration, according to the Sanger sequencing method. We proved that mutant lines with the intended gene alteration but no transplanted DNA showed OsHDT701 gene-induced allele mutation. The recombinant clone was confirmed with M13 primers. Phenotypic and agronomic traits such as the height of the plant, size, shape, length of the leaf, panicle length, and leaf response were examined in the mutated homozygous plants for blast resistance. In comparison with the wild-type plants, all mutant lines had significantly fewer blast lesions caused due to pathogen infection. In addition, none of the mutated and the wild plants significantly differed from one another in terms of the agronomic traits when examined visually. Our findings suggest that the CRISPR/Cas9 gene editing system is a practical method for enhancing rice blast resistance.

Key words: Blast, OsHDT701, Recombinant clone, Mutant lines, Wild-type plants






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.